Literature DB >> 10760692

Increased expression after X-irradiation of MUC1 in cultured human colon carcinoma HT-29 cells.

Y Kang1, K Hirano, N Suzuki, A Enomoto, A Morita, T Irimura, K Sakai.   

Abstract

The effect of X-irradiation on production of MUC1 was studied with human colon carcinoma HT-29 cells. As evaluated by immunocytochemical staining, the percentages of MUC1-positive cells in cells at 4 days after 6 Gy irradiation and in unirradiated control cells were 52 +/- 3.5% (n = 6) and 26 +/- 2.8% (n = 6), respectively. Flow-cytometric analysis of living cells showed that MUC1 began to rise from day 1, reaching a plateau by day 4 after 6 Gy irradiation. Western blot analysis with monoclonal antibody MY.1E12 against glycosylated MUC1 (mature form) showed dose-dependent increases of two bands (500 and 390 kDa) corresponding to two polymorphic MUC1 alleles. Premature forms of MUC1 (350 and 240 kDa) were detectable with monoclonal antibody HMFG-2 only in irradiated cells, suggesting that new core protein synthesis had been induced. The transcriptional activity of the MUC1 gene was analyzed in terms of transient expression of MUC1-CAT reporter plasmids containing 5'-flanking sequences of the MUC1 gene fused to the bacterial chloramphenicol acetyltransferase (CAT) gene. The results of CAT assay indicate that enhanced expression of MUC1 in irradiated HT-29 cells was due to upregulation of MUC1 transcription, and required the upstream promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760692      PMCID: PMC5926364          DOI: 10.1111/j.1349-7006.2000.tb00948.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Identification and characterization of a protein found after X-irradiation in human T cell leukemia.

Authors:  A Morimatsu; N Suzuki; K Hirano; Y Matsumoto; K Sakai
Journal:  J Radiat Res       Date:  1996-03       Impact factor: 2.724

2.  Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

Authors:  K O Lloyd; J Burchell; V Kudryashov; B W Yin; J Taylor-Papadimitriou
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

3.  Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues.

Authors:  T Irimura; D A Carlson; J Price; T Yamori; R Giavazzi; D M Ota; K R Cleary
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

4.  A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.

Authors:  A Girling; J Bartkova; J Burchell; S Gendler; C Gillett; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

5.  Regulation of sialomucin production in colon carcinoma cells.

Authors:  D F Dohi; R C Sutton; M L Frazier; S Nakamori; A M McIsaac; T Irimura
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

6.  Analysis of the tissue-specific promoter of the MUC1 gene.

Authors:  A Kovarik; N Peat; D Wilson; S J Gendler; J Taylor-Papadimitriou
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

7.  Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids.

Authors:  J J Ho; S Cheng; Y S Kim
Journal:  Biochem Biophys Res Commun       Date:  1995-05-25       Impact factor: 3.575

8.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

9.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Authors:  J Wesseling; S W van der Valk; H L Vos; A Sonnenberg; J Hilkens
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

10.  A novel monoclonal antibody specific for sialylated MUC1 mucin.

Authors:  M Yamamoto; V P Bhavanandan; S Nakamori; T Irimura
Journal:  Jpn J Cancer Res       Date:  1996-05
View more
  3 in total

1.  Unresectable stage III non-small cell lung cancer: is Tecemotide a new START for our patients?

Authors:  Els Wauters; Johan Vansteenkiste
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

2.  Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.

Authors:  Alexander Gelbard; Charlie T Garnett; Scott I Abrams; Vyomesh Patel; J Silvio Gutkind; Claudia Palena; Kwong-Yok Tsang; Jeffrey Schlom; James W Hodge
Journal:  Clin Cancer Res       Date:  2006-03-15       Impact factor: 12.531

3.  MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells.

Authors:  Tian-Qiao Huang; Ya-Nan Bi; Zheng Cui; Jin-Ping Guan; Yi-Chuan Huang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.